Gossamer Bio Inc.
GOSS | NASDAQ
$11.28
+$0.55 (+5.13%)
At close: Sep 21, 2026, 4:00 PM ET
$11.32
+$0.04 (+0.35%)
Pre-market:
Sep 22, 2026, 4:05 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 48.47M | 114.7M | n/a | n/a | n/a | n/a |
Cost of Revenue | 1M | n/a | n/a | n/a | n/a | 4.27M |
Gross Profit | 47.47M | 114.7M | n/a | n/a | n/a | -4.27M |
Operating Income | -163.25M | -59.92M | -183.76M | -218.59M | -216.12M | -210.58M |
Interest Income | 1.97M | 1.78M | 2M | 1.58M | 761K | 3.44M |
Pretax Income | -170.46M | -55.64M | -179.82M | -229.38M | -234M | -243.36M |
Net Income | -170.37M | -56.53M | -179.82M | -229.38M | -234M | -243.36M |
Selling & General & Admin | 37.63M | 36.13M | 38.46M | 47.61M | 45.78M | 48.32M |
Research & Development | 174.09M | 138.49M | 135.3M | 170.92M | 170.27M | 158M |
Other Expenses | -1M | n/a | 10M | 65K | 75K | n/a |
Operating Expenses | 210.72M | 174.62M | 183.76M | 218.59M | 216.12M | 206.31M |
Interest Expense | 10.99M | 11.52M | 13.51M | 13.88M | 19.44M | 12.67M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 211.72M | 174.62M | 183.76M | 218.59M | 216.12M | 210.58M |
Income Tax Expense | -88K | 893K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 228.52M | 226.23M | 225.57M | 84.57M | 74.84M | 68.51M |
Shares Outstanding (Diluted) | 228.52M | 226.23M | 225.57M | 84.57M | 74.84M | 68.51M |
EPS (Basic) | -0.75 | -0.25 | -0.80 | -2.84 | -3.33 | -3.67 |
EPS (Diluted) | -0.75 | -0.25 | -1.18 | -2.84 | -3.33 | -3.67 |
EBITDA | -158.47M | -39.97M | -161.92M | -211.07M | -209.4M | -226.43M |
EBIT | -159.47M | -44.12M | -166.31M | -215.5M | -214.56M | -230.69M |
Depreciation & Amortization | 1M | 4.15M | 4.39M | 4.43M | 5.17M | 4.27M |
Add to Watchlist
Select watchlists to add or remove GOSS